Last viewed:
SNY
Prices are updated after-hours
SNY
|
News
|
$48.49
-0.66%
-0.66%
1.1M
|
Health Technology
(0.0% 1d)
(-0.1% 1m)
(-6.2% 1y)
(-1.3% 2d)
(-0.4% 3d)
(-0.7% 7d)
(NaN%
volume)
Earnings Calendar:
Market Cap: $ 122,929,662,362
http://www.sanofi.com
Sec
Filling
|
Patents
| 100409 employees
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
vaccine
cardiovascular
diabetes
diabetic
add to watch list
email alert is off
Press-releases
Press Release: Dupixent® (dupilumab) recommended for expanded EU approval by the CHMP to treat children as young as six months old with severe atopic dermatitis
Published: 2023-01-27
(Crawled : 07:00)
- globenewswire.com
SNY
|
News
|
$48.49
-0.66%
-0.66%
1.1M
|
Health Technology
| -1.25%
| O: -1.25%
H: 0.0%
C: 0.0%
REGN
|
News
|
$742.84
0.07%
0.07%
410K
|
Health Technology
| 0.5%
| O: 0.5%
H: 0.0%
C: 0.0%
dupixent
for
chmp
children
six
dermatitis
approval
Dupixent® (dupilumab) Recommended for Expanded EU Approval by the CHMP to Treat Children as Young as Six Months Old with Severe Atopic Dermatitis
Published: 2023-01-27
(Crawled : 12:20)
- globenewswire.com
SNY
|
News
|
$48.49
-0.66%
-0.66%
1.1M
|
Health Technology
| -1.25%
| O: -1.25%
H: 0.0%
C: 0.0%
REGN
|
News
|
$742.84
0.07%
0.07%
410K
|
Health Technology
| 0.5%
| O: 0.5%
H: 0.0%
C: 0.0%
dupixent
for
chmp
children
six
dermatitis
approval
Europe Human Papillomavirus Vaccine Market Report 2022: Sector to Reach $1.59 Billion by 2028 at a 4.9% CAGR
Published: 2023-01-27
(Crawled : 01:00)
- prnewswire.com
GSK
|
News
|
$35.3
-0.11%
0.14%
3.5M
|
Health Technology
| 0.06%
| O: 0.06%
H: 0.0%
C: 0.0%
SNY
|
News
|
$48.49
-0.66%
-0.66%
1.1M
|
Health Technology
| -1.25%
| O: -1.25%
H: 0.0%
C: 0.0%
europe
report
vaccine
market
Global Infertility Drugs Market Report 2022: Sector to Reach $4.8 Billion by 2028 at a 6.2% CAGR
Published: 2023-01-26
(Crawled : 00:00)
- prnewswire.com
PFE
|
$43.79
-1.04%
0.0%
23M
|
Health Technology
| -0.05%
| O: -0.05%
H: 0.0%
C: 0.0%
NVS
|
News
4
d
|
$89.49
-0.39%
0.01%
1.7M
|
Health Technology
| -1.77%
| O: -1.77%
H: 0.0%
C: 0.0%
ABT
|
News
|
$109.95
-1.01%
0.0%
4.9M
|
Health Technology
| -0.74%
| O: -0.74%
H: 0.0%
C: 0.0%
SNY
|
News
|
$48.49
-0.66%
-0.66%
1.1M
|
Health Technology
| -1.25%
| O: -1.25%
H: 0.0%
C: 0.0%
global
report
market
Data Center Accelerator Global Market Report 2022: Sector to Reach $73.31 Billion by 2030
Published: 2023-01-26
(Crawled : 22:00)
- prnewswire.com
SNY
|
News
|
$48.49
-0.66%
-0.66%
1.1M
|
Health Technology
| -1.25%
| O: -1.25%
H: 0.0%
C: 0.0%
INTC
|
News
|
$28.155
-6.43%
-7.46%
150M
|
Electronic Technology
| -10.17%
| O: -10.17%
H: 0.0%
C: 0.0%
global
report
market
CPD Clinical Trial Administrator (CTA) Beginner Course (February 6-21, 2023)
Published: 2023-01-26
(Crawled : 13:00)
- prnewswire.com
SNYNF
|
News
|
$97.85
0
|
Health Technology
| -0.49%
| O: -0.49%
H: 0.0%
C: 0.0%
JNJ
|
News
3
d
|
$168.23
-0.39%
-0.04%
6M
|
Health Technology
| 0.78%
| O: 1.29%
H: 0.0%
C: 0.0%
SNY
|
News
|
$48.49
-0.66%
-0.66%
1.1M
|
Health Technology
| -0.37%
| O: 0.89%
H: 0.0%
C: 0.0%
trial
HBM Alpha Therapeutics Raises Seed Round to Advance Next-Gen Therapies for Endocrine Disorders
Published: 2023-01-26
(Crawled : 02:00)
- prnewswire.com
SNYNF
|
News
|
$97.85
0
|
Health Technology
| -0.49%
| O: -0.49%
H: 0.0%
C: 0.0%
SNY
|
News
|
$48.49
-0.66%
-0.66%
1.1M
|
Health Technology
| -0.37%
| O: 0.89%
H: 0.0%
C: 0.0%
for
endocrine
therapeutics
Worldwide Orthopedic Oncology Treatment Industry to 2030 - Dominating Segment is Reconstructive Surgery
Published: 2023-01-26
(Crawled : 01:00)
- prnewswire.com
SNYNF
|
News
|
$97.85
0
|
Health Technology
| -0.49%
| O: -0.49%
H: 0.0%
C: 0.0%
NVSEF
|
News
4
d
|
$90.0
0
|
Health Technology
| -1.1%
| O: -1.1%
H: 0.0%
C: 0.0%
ZBH
|
News
|
$125.88
0.3%
0.0%
1.4M
|
Health Technology
| 0.48%
| O: 1.12%
H: 0.0%
C: 0.0%
SYK
|
News
|
$254.17
0.7%
0.0%
1M
|
Health Technology
| -0.05%
| O: 0.78%
H: 0.0%
C: 0.0%
NVS
|
News
4
d
|
$89.49
-0.39%
0.01%
1.7M
|
Health Technology
| -3.0%
| O: -1.25%
H: 0.0%
C: 0.0%
JNJ
|
News
3
d
|
$168.23
-0.39%
-0.04%
6M
|
Health Technology
| 0.78%
| O: 1.29%
H: 0.0%
C: 0.0%
SNY
|
News
|
$48.49
-0.66%
-0.66%
1.1M
|
Health Technology
| -0.37%
| O: 0.89%
H: 0.0%
C: 0.0%
treatment
Pharmaceutical API Manufacturing Global Market Report 2022: Sector to Reach $248 Billion by 2026 at a 6% CAGR
Published: 2023-01-25
(Crawled : 23:00)
- prnewswire.com
SNYNF
|
News
|
$97.85
0
|
Health Technology
| -0.49%
| O: -0.49%
H: 0.0%
C: 0.0%
SNY
|
News
|
$48.49
-0.66%
-0.66%
1.1M
|
Health Technology
| -0.37%
| O: 0.89%
H: 0.0%
C: 0.0%
global
report
market
Press Release: NEJM publishes once-weekly efanesoctocog alfa Phase 3 data demonstrating its potential to transform the treatment landscape for people with hemophilia A
Published: 2023-01-25
(Crawled : 23:00)
- globenewswire.com
SNYNF
|
News
|
$97.85
0
|
Health Technology
| -0.49%
| O: -0.49%
H: 0.0%
C: 0.0%
SNY
|
News
|
$48.49
-0.66%
-0.66%
1.1M
|
Health Technology
| -0.37%
| O: 0.89%
H: 0.0%
C: 0.0%
treatment
for
potential
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount